Cisapride and erythromycin prokinetic effects in gastroparesis due to type 1 (insulin‐dependent) diabetes mellitus

Abstract

Erythromycin may represent an effective therapeutic alternative to more established forms of treatment in patients with diabetic gastroparesis, especially when other drugs have failed.